You’ve run a number of life sciences companies now, but before that you started Telephia, an information services provider to the wireless industry. How did you…
In Conversation
What initially attracted you to China and what kept you here over the years? I initially became interested in China during university where I studied the…
You have had significant experience at GSK and Pfizer, and also at Frontage Labs doing more entrepreneurial work. What ultimately brought you to Covance? I worked…
Could you please give us a brief introduction on CMBA? First and most obviously for new arrivals to our office, since 2011 we have changed locations,…
Your background before joining Beaufour Ipsen is quite unique among country managers of pharmaceutical companies: working many years in academia and focused very much on Asian…
In 2006, Genzyme’s global CEO, Henri Termeer, said he is “personally very interested in China” and that he expects the company to build a capable infrastructure…
Maver has an impressive track record in developing and commercializing blockbuster products for the Chilean market, such as Tapsin and Disfruta, which today are the #1…
What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile? Chile, in the regional context, represents a very important market with a…
What was the transition like from academia into entrepreneurship and what challenges did you face in beginning this company? I realized during this period in the…
The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing main milestones and achievements of the company since you have been…
As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key…
“ "There is an ageing population [in China] with an epidemiological profile that is increasingly aligned with that of the West. These are elements that favor global… ”
